The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Open accessAbstract
After the global spread of SARS-CoV-2 Omicron BA.2 lineage, some BA.2-related variants that acquire mutations in the L452 residue of spike protein, such as BA.2.9.1 and BA.2.13 (L452M), BA.2.12.1 (L452Q), and BA.2.11, BA.4 and BA.5 (L452R), emerged in multiple countries. Our statistical analysis showed that the effective reproduction numbers of these L452R/M/Q-bearing BA.2-related Omicron variants are greater than that of the original BA.2. Neutralization experiments revealed that the immunity induced by BA.1 and BA.2 infections is less effective against BA.4/5. Cell culture experiments showed that BA.2.12.1 and BA.4/5 replicate more efficiently in human alveolar epithelial cells than BA.2, and particularly, BA.4/5 is more fusogenic than BA.2. Furthermore, infection experiments using hamsters indicated that BA.4/5 is more pathogenic than BA.2. Altogether, our multiscale investigations suggest that the risk of L452R/M/Q-bearing BA.2-related Omicron variants, particularly BA.4 and BA.5, to global health is potentially greater than that of original BA.2. Highlights Spike L452R/Q/M mutations increase the effective reproduction number of BA.2 BA.4/5 is resistant to the immunity induced by BA.1 and BA.2 infections BA.2.12.1 and BA.4/5 more efficiently spread in human lung cells than BA.2 BA.4/5 is more pathogenic than BA.2 in hamsters
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu033 · Cited by 32,291
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
fastp: an ultra-fast all-in-one FASTQ preprocessor
Chen, S., Zhou, Y., Chen, Y., & Gu, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty560 · Cited by 29,721
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612 · cited 4×
“10.4 Global Phasing Ltd. https://www.globalphasing.com/ MolProbity Duke Biochemistry http://molprobity.biochem.duke.edu/ index.php COOT Emsley and Cowtan, 2004 http://www.mrc-lmb.cam.ac.uk/ personal/peemsley/coot/ Phaser McCoy et al., 2007 https://www.phaser.cimr.cam.ac.uk/ index.php/Phaser_Crystallographic_ Software…”
InfluentialA SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
Minimap2: Pairwise alignment for nucleotide sequences
Li, H. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty191 · Cited by 14,807
trimAl: a tool for automated alignment trimming in large-scale phylogenetic analyses
Capella-Gutiérrez, S., Silla-Martínez, J. M., & Gabaldón, T. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp348 · Cited by 12,751
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Self-citationStructure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Cao, Y., Wang, J., Jian, F., Xiao, T., Song, W., Yisimayi, A., Huang, W., Li, Q., Wang, P., An, R., et al. (2022) · Nature · doi:10.1038/s41586-021-04385-3 · Cited by 2,006
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Planas, D., Saunders, N., Maes, P., Guivel-Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W.-H., Porrot, F., Staropoli, I., Lemoine, F., et al. (2022) · Nature · doi:10.1038/s41586-021-04389-z · Cited by 1,514
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Matsuyama, S., Nao, N., Shirato, K., Kawase, M., Saito, S., Takayama, I., Nagata, N., Sekizuka, T., Katoh, H., Kato, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002589117 · Cited by 1,411
Self-citationMultiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Garcia-Beltran, W. F., Lam, E. C., St. Denis, K., Nitido, A. D., Garcia, Z. H., Hauser, B. M., Feldman, J., Pavlovic, M. N., Gregory, D. J., Poznansky, M. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.013 · Cited by 1,353
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Cao, Y., Yisimayi, A., Jian, F., Song, W., Xiao, T., Wang, L., Du, S., Wang, J., Li, Q., Chen, X., et al. (2022) · Nature · doi:10.1038/s41586-022-04980-y · Cited by 1,335
Self-citationCele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D., et al. (2021) · doi:10.1101/2021.12.08.21267417 · Cited by 1,333
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Liu, L., Iketani, S., Guo, Y., Chan, J. F.-W., Wang, M., Liu, L., Luo, Y., Chu, H., Huang, Y., Nair, M. S., et al. (2022) · Nature · doi:10.1038/s41586-021-04388-0 · Cited by 1,290
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Meng, B., Abdullahi, A., Ferreira, I. A. T. M., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerber, P. P., Fatihi, S., Rathore, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04474-x · Cited by 1,146
Self-citationGISAID’s Role in Pandemic Response
Khare, S., GISAID Global Data Science Initiative (GISAID), M., Gurry, C., Freitas, L., B Schultz, M., Bach, G., Diallo, A., Akite, N., Ho, J., TC Lee, R., et al. (2021) · China CDC Weekly · doi:10.46234/ccdcw2021.255 · Cited by 1,054
Sheikh, A., McMenamin, J., Taylor, B., & Robertson, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01358-1 · Cited by 939
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai, W., Huo, J., Zhou, D., Zahradník, J., Supasa, P., Liu, C., Duyvesteyn, H. M. E., Ginn, H. M., Mentzer, A. J., Tuekprakhon, A., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.046 · Cited by 930 · cited 8×
“A yeast surface display assay using the SARSCoV-2 S RBD and soluble human ACE2 (Dejnirattisai et al., 2022; Kimura et al., 2022a, 2022b; Motozono et al., 2021; Yamasoba et al., 2022b; Zahradnı́k et al., 2021a) showed that the KD value of the BA.”
InfluentialSelf-citationSARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
Hui, K. P. Y., Ho, J. C. W., Cheung, M.-C., Ng, K.-C., Ching, R. H. H., Lai, K.-L., Kam, T. T., Gu, H., Sit, K.-Y., Hsin, M. K. Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04479-6 · Cited by 836
Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., Seaman, S. R., Harris, R. J., Hope, R., Lopez-Bernal, J., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00475-8 · Cited by 803
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Wang, Q., Guo, Y., Iketani, S., Nair, M. S., Li, Z., Mohri, H., Wang, M., Yu, J., Bowen, A. D., Chang, J. Y., et al. (2022) · Nature · doi:10.1038/s41586-022-05053-w · Cited by 775
Automated minimization of steric clashes in protein structures
Ramachandran, S., Kota, P., Ding, F., & Dokholyan, N. V. (2011) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22879 · Cited by 725
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
Tegally, H., Moir, M., Everatt, J., Giovanetti, M., Scheepers, C., Wilkinson, E., Subramoney, K., Makatini, Z., Moyo, S., Amoako, D. G., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01911-2 · Cited by 707
VanBlargan, L. A., Errico, J. M., Halfmann, P. J., Zost, S. J., Crowe, J. E., Purcell, L. A., Kawaoka, Y., Corti, D., Fremont, D. H., & Diamond, M. S. (2022) · Nature Medicine · doi:10.1038/s41591-021-01678-y · Cited by 705
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon, A., Nutalai, R., Dijokaite-Guraliuc, A., Zhou, D., Ginn, H. M., Selvaraj, M., Liu, C., Mentzer, A. J., Supasa, P., Duyvesteyn, H. M. E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.005 · Cited by 686
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
Suzuki, R., Yamasoba, D., Kimura, I., Wang, L., Kishimoto, M., Ito, J., Morioka, Y., Nao, N., Nasser, H., Uriu, K., et al. (2022) · Nature · doi:10.1038/s41586-022-04462-1 · Cited by 682
Self-citationPolder maps: improving OMIT maps by excluding bulk solvent
Liebschner, D., Afonine, P. V., Moriarty, N. W., Poon, B. K., Sobolev, O. V., Terwilliger, T. C., & Adams, P. D. (2017) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798316018210 · Cited by 657
Reeves, P. J., Callewaert, N., Contreras, R., & Khorana, H. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519299 · Cited by 640
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
Saito, A., Irie, T., Suzuki, R., Maemura, T., Nasser, H., Uriu, K., Kosugi, Y., Shirakawa, K., Sadamasu, K., Kimura, I., et al. (2022) · Nature · doi:10.1038/s41586-021-04266-9 · Cited by 615
Self-citationSARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Motozono, C., Toyoda, M., Zahradnik, J., Saito, A., Nasser, H., Tan, T. S., Ngare, I., Kimura, I., Uriu, K., Kosugi, Y., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.006 · Cited by 586
Self-citationEfficient comparative phylogenetics on large trees
Louca, S., & Doebeli, M. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx701 · Cited by 564 · cited 4×
“Second, we identified the branches connecting the parental-state (L) nodes and the mutated-sate (R, Q, or M) nodes (red branches in Figure S1C).”
InfluentialNeutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
Hachmann, N. P., Miller, J., Collier, A.-R. Y., Ventura, J. D., Yu, J., Rowe, M., Bondzie, E. A., Powers, O., Surve, N., Hall, K., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2206576 · Cited by 550
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
Ozono, S., Zhang, Y., Ode, H., Sano, K., Tan, T. S., Imai, K., Miyoshi, K., Kishigami, S., Ueno, T., Iwatani, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21118-2 · Cited by 535
Self-citationTwohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M., Aliabadi, S., Seaman, S. R., Harris, R., Hope, R., Bernal, J. L., et al. (2021) · Northumbria Research Link (Northumbria University) · doi:10.17863/cam.76294 · Cited by 514
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
Han, P., Li, L., Liu, S., Wang, Q., Zhang, D., Xu, Z., Han, P., Li, X., Peng, Q., Su, C., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.001 · Cited by 490
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
Zahradník, J., Marciano, S., Shemesh, M., Zoler, E., Harari, D., Chiaravalli, J., Meyer, B., Rudich, Y., Li, C., Marton, I., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00954-4 · Cited by 457
Self-citationRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Meng, B., Kemp, S. A., Papa, G., Datir, R., Ferreira, I. A. T. M., Marelli, S., Harvey, W. T., Lytras, S., Mohamed, A., Gallo, G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109292 · Cited by 405
Ong, S. W. X., Chiew, C. J., Ang, L. W., Mak, T. M., Cui, L., Toh, M. P. H. S., Lim, Y. D., Lee, P. H., Lee, T. H., Chia, P. Y., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab721 · Cited by 384
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Yamasoba, D., Kimura, I., Nasser, H., Morioka, Y., Nao, N., Ito, J., Uriu, K., Tsuda, M., Zahradnik, J., Shirakawa, K., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.035 · Cited by 380
Self-citationEfficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
Takashita, E., Kinoshita, N., Yamayoshi, S., Sakai-Tagawa, Y., Fujisaki, S., Ito, M., Iwatsuki-Horimoto, K., Chiba, S., Halfmann, P., Nagai, H., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2119407 · Cited by 376
Gotoh, S., Ito, I., Nagasaki, T., Yamamoto, Y., Konishi, S., Korogi, Y., Matsumoto, H., Muro, S., Hirai, T., Funato, M., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.07.005 · Cited by 325
Self-citationEfficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
Takashita, E., Kinoshita, N., Yamayoshi, S., Sakai-Tagawa, Y., Fujisaki, S., Ito, M., Iwatsuki‐Horimoto, K., Halfmann, P., Watanabe, S., Maeda, K., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2201933 · Cited by 290
Bruel, T., Hadjadj, J., Maes, P., Planas, D., Seve, A., Staropoli, I., Guivel-Benhassine, F., Porrot, F., Bolland, W.-H., Nguyen, Y., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01792-5 · Cited by 282
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Uraki, R., Kiso, M., Iida, S., Imai, M., Takashita, E., Kuroda, M., Halfmann, P. J., Loeber, S., Maemura, T., Yamayoshi, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04856-1 · Cited by 273
Self-citationLong-term expansion of alveolar stem cells derived from human iPS cells in organoids
Yamamoto, Y., Gotoh, S., Korogi, Y., Seki, M., Konishi, S., Ikeo, S., Sone, N., Nagasaki, T., Matsumoto, H., Muro, S., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4448 · Cited by 270
Self-citationYamamoto, M., Kiso, M., Sakai-Tagawa, Y., Iwatsuki-Horimoto, K., Imai, M., Takeda, M., Kinoshita, N., Ohmagari, N., Gohda, J., Semba, K., et al. (2020) · Viruses · doi:10.3390/v12060629 · Cited by 268
Konishi, S., Gotoh, S., Tateishi, K., Yamamoto, Y., Korogi, Y., Nagasaki, T., Matsumoto, H., Muro, S., Hirai, T., Ito, I., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.11.010 · Cited by 246
Self-citationMultiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Garcia-Beltran, W. F., Lam, E. C., St. Denis, K., Nitido, A. D., Garcia, Z. H., Hauser, B. M., Feldman, J., Pavlovic, M. N., Gregory, D. J., Poznansky, M. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.006 · Cited by 243
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Khan, K., Karim, F., Ganga, Y., Bernstein, M., Jule, Z., Reedoy, K., Cele, S., Lustig, G., Amoako, D., Wolter, N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32396-9 · Cited by 230
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Cao, Y., Wang, J., Jian, F., Xiao, T., Song, W., Yisimayi, A., Huang, W., Li, Q., Wang, P., An, R., et al. (2021) · Nature · doi:10.1038/d41586-021-03796-6 · Cited by 227
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Kimura, I., Kosugi, Y., Wu, J., Zahradnik, J., Yamasoba, D., Butlertanaka, E. P., Tanaka, Y. L., Uriu, K., Liu, Y., Morizako, N., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110218 · Cited by 218
Self-citationNeutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
Uriu, K., Kimura, I., Shirakawa, K., Takaori-Kondo, A., Nakada, T.-A., Kaneda, A., Nakagawa, S., & Sato, K. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2114706 · Cited by 214
Self-citationNeutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
Yamasoba, D., Kosugi, Y., Kimura, I., Fujita, S., Uriu, K., Ito, J., & Sato, K. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00365-6 · Cited by 202
Self-citationVirological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Saito, A., Tamura, T., Zahradnik, J., Deguchi, S., Tabata, K., Anraku, Y., Kimura, I., Ito, J., Yamasoba, D., Nasser, H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.10.003 · Cited by 199
Self-citationConsiderable escape of SARS-CoV-2 Omicron to antibody neutralization
Planas, D., Saunders, N., Maes, P., Guivel‐Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W., Porrot, F., Staropoli, I., Lemoine, F., et al. (2021) · Nature · doi:10.1038/d41586-021-03827-2 · Cited by 197
Torii, S., Ono, C., Suzuki, R., Morioka, Y., Anzai, I., Fauzyah, Y., Maeda, Y., Kamitani, W., Fukuhara, T., & Matsuura, Y. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109014 · Cited by 180
Self-citationOmicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D. G., et al. (2021) · Nature · doi:10.1038/d41586-021-03824-5 · Cited by 178
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
Qu, P., Faraone, J., Evans, J. P., Zou, X., Zheng, Y.-M., Carlin, C., Bednash, J. S., Lozanski, G., Mallampalli, R. K., Saif, L. J., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2206725 · Cited by 161
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Lyke, K. E., Atmar, R. L., Islas, C. D., Posavad, C. M., Szydlo, D., Paul Chourdhury, R., Deming, M. E., Eaton, A., Jackson, L. A., Branche, A. R., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100679 · Cited by 153
Aggarwal, A., Akerman, A., Milogiannakis, V., Silva, M. R., Walker, G. J., Stella, A. O., Kindinger, A., Angelovich, T. A., Waring, E., Amatayakul‐Chantler, S., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104270 · Cited by 152
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
Ferreira, I. A. T. M., Kemp, S. A., Datir, R., Saito, A., Meng, B., Rakshit, P., Takaori-Kondo, A., Kosugi, Y., Uriu, K., Kimura, I., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab368 · Cited by 151
Self-citationProtective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
Altarawneh, H. N., Chemaitelly, H. S., Ayoub, H. H., Hasan, M. R., Coyle, P. V., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Kanaani, Z. A., Al‐Kuwari, E., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2209306 · Cited by 146
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
Jocher, G., Grass, V., Tschirner, S. K., Riepler, L., Breimann, S., Kaya, T., Oelsner, M., Hamad, M. S., Hofmann, L. I., Blobel, C., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154305 · Cited by 139
Neutralization of SARS-CoV-2 Omicron Sub-lineages BA.1, BA.1.1, and BA.2
Evans, J. P., Zeng, C., Qu, P.-K., Faraone, J. N., Zheng, Y.-M., Carlin, C., Bednash, J., Zhou, T., Lozanski, G., Mallampalli, R., et al. (2022) · Cell Host and Microbe · doi:10.1016/j.chom.2022.04.014 · Cited by 136
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
Uraki, R., Halfmann, P., Iida, S., Yamayoshi, S., Furusawa, Y., Kiso, M., Ito, M., Iwatsuki‐Horimoto, K., Mine, S., Kuroda, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05482-7 · Cited by 106
Self-citationAugmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
Arora, P., Kempf, A. M., Nehlmeier, I., Schulz, S. R., Cossmann, A., Stankov, M. V., Jäck, H., Behrens, G. M. N., Pöhlmann, S., & Hoffmann, M. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00422-4 · Cited by 98
Eukaryotic expression: developments for structural proteomics
Aricescu, A. R., Assenberg, R., Bill, R. M., Busso, D., Chang, V. T.-C., Davis, S. J., Dubrovsky, A. L., Gustafsson, L., Hedfalk, K., Heinemann, U., et al. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906029805 · Cited by 97
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
Rössler, A., Knabl, L., von Laer, D., & Kimpel, J. (2022) · New England Journal of Medicine · doi:10.1056/nejmc2201607 · Cited by 95
Wolter, N., Jassat, W., Walaza, S., Welch, R., Moultrie, H., Groome, M. J., Amoako, D. G., Everatt, J., Bhiman, J. N., Scheepers, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33614-0 · Cited by 91
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Reuschl, A., Thorne, L., Whelan, M. V. X., Ragazzini, R., Furnon, W., Cowton, V. M., Lorenzo, G. D., Mesner, D., Turner, J. L. E., Dowgier, G., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01588-4 · Cited by 84
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Rössler, A., Netzl, A., Knabl, L., Schäfer, H., Wilks, S., Bante, D., Falkensammer, B., Borena, W., von Laer, D., Smith, D. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35312-3 · Cited by 79
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
Gruell, H., Vanshylla, K., Korenkov, M., Tober-Lau, P., Zehner, M., Münn, F., Janicki, H., Augustin, M., Schommers, P., Sander, L., et al. (2022) · Cell Host and Microbe · doi:10.1016/j.chom.2022.07.002 · Cited by 69
Wang, W., Lusvarghi, S., Subramanian, R., Epsi, N. J., Wang, R., Goguet, E., Fries, A. C., Echegaray, F., Vassell, R., Coggins, S., et al. (2022) · doi:10.1101/2022.07.05.498883 · Cited by 68
Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag
Ozono, S., Zhang, Y., Tobiume, M., Kishigami, S., & Tokunaga, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013887 · Cited by 62
Wang, W., Lusvarghi, S., Subramanian, R., Epsi, N. J., Wang, R., Goguet, E., Fries, A. C., Echegaray, F., Vassell, R. A., Coggins, S. A., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.10.012 · Cited by 61
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant
Kimura, I., Yamasoba, D., Nasser, H., Zahradník, J., Kosugi, Y., Wu, J., Nagata, K., Uriu, K., Tanaka, Y., Ito, J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105720 · Cited by 51
Self-citationMonitoring Viral‐Mediated Membrane Fusion Using Fluorescent Reporter Methods
Kondo, N., Miyauchi, K., & Matsuda, Z. (2011) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb2609s50 · Cited by 49
Ito, K., Piantham, C., & Nishiura, H. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2022418 · Cited by 47
A Protein-Engineered, Enhanced Yeast Display Platform for Rapid Evolution of Challenging Targets
Zahradník, J., Dey, D., Marciano, S., Kolářová, L., Charendoff, C. I., Subtil, A., & Schreiber, G. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00395 · Cited by 43
Self-citationAbbas, Q., Викторович, К. А., Sharrouf, K. A., Jyakhwo, S., & Komissarov, A. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.25.481941 · Cited by 19
Uriu, K., Cárdenas, P., Muñoz, E., Barragán, V. A., Kosugi, Y., Shirakawa, K., Takaori-Kondo, A., & Sato, K. (2022) · Journal of Infectious Diseases · doi:10.1093/infdis/jiac053 · Cited by 16
Self-citationOmicron Infection Induces Low-Level, Narrow-Range SARS-CoV-2 Neutralizing ActivityPreprint
Turelli, P., Zaballa, M.-E., Raclot, C., Fenwick, C. W., Kaiser, L., Eckerle, I., Pantaleo, G., Guessous, I., Stringhini, S., & Trono, D. (2022) · SSRN Electronic Journal · doi:10.1101/2022.05.02.22274436 · Cited by 4
Cited by
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Carabelli, A. M., Peacock, T. P., Thorne, L. G., Harvey, W. T., Hughes, J., COVID-19 Genomics UK Consortium, de Silva, T. I., Peacock, S. J., Barclay, W. S., de Silva, T. I., et al. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00841-7 · Cited by 1,291
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Cao, Y., Jian, F., Wang, J., Yu, Y., Song, W., Yisimayi, A., Wang, J., An, R., Chen, X., Zhang, N., et al. (2023) · Nature · doi:10.1038/s41586-022-05644-7 · Cited by 841
Tamura, T., Ito, J., Uriu, K., Zahradnik, J., Kida, I., Anraku, Y., Nasser, H., Shofa, M., Oda, Y., Lytras, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38435-3 · Cited by 340
Self-citationQu, P., Evans, J. P., Faraone, J. N., Zheng, Y.-M., Carlin, C., Anghelina, M., Stevens, P., Fernandez, S., Jones, D., Lozanski, G., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2022.11.012 · Cited by 261
Kislaya, I., Casaca, P., Borges, V., Sousa, C., Ferreira, B. I., Fonte, A., Fernandes, E., Matias Dias, C., Duarte, S., Almeida, J. P., et al. (2022) · doi:10.2139/ssrn.4180482 · Cited by 5
Metadata
- Authors
- Kimura, I., Yamasoba, D., Tamura, T., Nao, N., Suzuki, T., Oda, Y., Mitoma, S., Ito, J., Nasser, H., Zahradnik, J., Uriu, K., Fujita, S., Kosugi, Y., Wang, L., Tsuda, M., Kishimoto, M., Ito, H., Suzuki, R., Shimizu, R., Begum, M. M., Yoshimatsu, K., Kimura, K. T., Sasaki, J., Sasaki-Tabata, K., Yamamoto, Y., Nagamoto, T., Kanamune, J., Kobiyama, K., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Shirakawa, K., Takaori-Kondo, A., Kuramochi, J., Schreiber, G., Ishii, K. J., Hashiguchi, T., Ikeda, T., Saito, A., Fukuhara, T., Tanaka, S., Matsuno, K., & Sato, K.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 185
- Issue
- 21
- Pages
- 3992-4007.e16
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4295777530
- Cited by
- 297
- References
- 89
- FWCI
- 32.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.